As a Ph.D. candidate at Johns Hopkins University School of Medicine specializing in immunotherapy and business development, I am passionate about translating scientific research into real-world therapeutic applications. My research focuses on advancing novel treatments for cancer, specifically through metabolic reprogramming and immunotherapy. I have contributed to therapies that have progressed to clinical trials and am a part of several high-impact publications.Beyond the lab, I bring a strong background in business development, which I’ve applied to evaluate the commercial potential of emerging therapeutics. My work as an intern analyst at Adventris Pharmaceuticals involved conducting market and competitive analysis, performing due diligence, and developing strategic recommendations to support investment decisions in cancer immunotherapy. I also have experience crafting marketing strategies and identifying opportunities for scaling operations, gained through my involvement with the Johns Hopkins Graduate Consulting Club.Driven by curiosity and a desire to make an impact, I am skilled in navigating fast-paced, collaborative environments. Whether it’s leading research projects or managing investor meetings, I can solve complex problems and deliver results. I thrive at the intersection of science and business and am eager to continue contributing to the development of life-saving therapeutics.